Cargando…
Utilization and Drug Cost Outcomes of a Step-Therapy Edit for Generic Antidepressants in an HMO in an Integrated Health System
OBJECTIVES: Antidepressants do not differ significantly in their ability to treat depression. Excluding the tricyclic antidepressants (TCAs), these drugs also do not differ significantly in their incidence of adverse events. Therefore, the initial choice of antidepressant medication should be based,...
Autores principales: | Dunn, Jeffrey D., Cannon, Eric, Mitchell, Matthew P., Curtiss, Frederic R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437751/ https://www.ncbi.nlm.nih.gov/pubmed/16792435 http://dx.doi.org/10.18553/jmcp.2006.12.4.294 |
Ejemplares similares
-
S/HMO Versus TEFRA HMO Enrollees: Analysis of Expenditures
por: Dowd, Bryan, et al.
Publicado: (1999) -
Cost and Outcomes of Medicare Reimbursement for HMO Preventive Services
por: Patrick, Donald L., et al.
Publicado: (1999) -
Clinical, Service, and Cost Outcomes of Drug Coverage Edits and Quanitity Limits
por: Curtiss, Frederic R.
Publicado: (2003) -
Step-Therapy Edits for PPIs and COX-2 Drugs - What We Do and Do Not Know
por: Curtiss, Frederic R.
Publicado: (2004) -
Prior Authorization to Manage Drug Utilization and Costs
por: Curtiss, Frederic R.
Publicado: (2003)